Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE II
2007-007127-40Phase 4Terminated
- Sponsor
- AstraZeneca
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of quetiapine in schizophrenia, schizoaffective disorder, schizophreniform disorder and 2 more (2 arms), sponsored by AstraZeneca. Started Feb 2008; status: terminated.
02
Drugs
quetiapine
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorderdelusional disorderUnspecified psychosis
Beyond the preview
Go deeper on 2007-007127-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007127-40.